Prestige Biologics Co., Ltd. (KOSDAQ:334970)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,760.00
-35.00 (-1.25%)
At close: Feb 27, 2026
-38.46%
Market Cap 214.60B
Revenue (ttm) 19.24B
Net Income (ttm) -28.23B
Shares Out 77.75M
EPS (ttm) -344.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 269,157
Average Volume 161,155
Open 2,795.00
Previous Close 2,795.00
Day's Range 2,695.00 - 2,795.00
52-Week Range 2,695.00 - 5,220.00
Beta 0.78
RSI 36.70
Earnings Date n/a

About Prestige Biologics

Prestige Biologics Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers budget finding, contract development, contract manufacturing, contract packaging, and analytical testing services. It also provides customized engineering solutions for manufacturing process under the ALITA Smart BioFactory brand name. Prestige Biologics Co., Ltd. was formerly known as PrestigeBio Pharmaceuticals and changed its name to Prestige Biologics Co., Ltd. in October 2019. The company was incorporated in 2015 and is based in Cheongju... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2015
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 334970
Full Company Profile

Financial Performance

In fiscal year 2025, Prestige Biologics's revenue was 12.53 billion, an increase of 477.83% compared to the previous year's 2.17 billion. Losses were -27.47 billion, -6.48% less than in 2024.

Financial Statements

News

There is no news available yet.